Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
European Journal of Medical Research
|
February 18, 2010
Bendamustine in patients with relapsed or refractory multiple myeloma
M Michael, I Bruns, E Bölke, et al.
Bone Marrow Transplantation
|
October 13, 2009
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
A Czibere, I Bruns, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 18, 2010
A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma
G Kobbe, I Bruns, T Schroeder, et al.
Bone Marrow Transplantation
|
November 9, 2004
Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma
U Steidl, R Fenk, I Bruns, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1999
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation
H L Tillmann, C Trautwein, T Bock, et al.
Leukemia
|
January 15, 2013
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
T Schroeder, A Czibere, U Platzbecker, et al.
Journal of Diabetes Science and Technology
|
November 21, 2019
Fifteen-minute Frequency of Glucose Measurements and the Use of Threshold Alarms: Impact on Mitigating Dysglycemia in Critically Ill Patients
Grant V Bochicchio, Stanley A Nasraway, Laura J Moore, et al.
Leukemia
|
June 26, 2013
Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells
S Geyh, S Oz, R-P Cadeddu, et al.
Leukemia
|
January 26, 2007
Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase
E Diaz-Blanco, I Bruns, F Neumann, et al.
Leukemia
|
January 23, 2009
The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence
I Bruns, A Czibere, J C Fischer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
European Journal of Medical Research
|
February 18, 2010
Bendamustine in patients with relapsed or refractory multiple myeloma
M Michael, I Bruns, E Bölke, et al.
Bone Marrow Transplantation
|
October 13, 2009
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
A Czibere, I Bruns, N Kröger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 18, 2010
A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma
G Kobbe, I Bruns, T Schroeder, et al.
Bone Marrow Transplantation
|
November 9, 2004
Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma
U Steidl, R Fenk, I Bruns, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1999
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation
H L Tillmann, C Trautwein, T Bock, et al.
Leukemia
|
January 15, 2013
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
T Schroeder, A Czibere, U Platzbecker, et al.
Journal of Diabetes Science and Technology
|
November 21, 2019
Fifteen-minute Frequency of Glucose Measurements and the Use of Threshold Alarms: Impact on Mitigating Dysglycemia in Critically Ill Patients
Grant V Bochicchio, Stanley A Nasraway, Laura J Moore, et al.
Leukemia
|
June 26, 2013
Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells
S Geyh, S Oz, R-P Cadeddu, et al.
Leukemia
|
January 26, 2007
Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase
E Diaz-Blanco, I Bruns, F Neumann, et al.
Leukemia
|
January 23, 2009
The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence
I Bruns, A Czibere, J C Fischer, et al.
Page
of 3